1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8 "Hepatology")
fax: 412-648-6399.
1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
Viral Hepatitis
You have full text access to this OnlineOpen article
Effect of hepatitis C virus and its treatment on survival†‡
Article first published online: 9 JUL 2009
DOI: 10.1002/hep.23000
Copyright © 2009 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Butt, A. A., Wang, X. and Moore, C. G. (2009), Effect of hepatitis C virus and its treatment on survival. Hepatology, 50: 387–392. doi: 10.1002/hep.23000
- †
The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs.
- ‡
Potential conflict of interest: Nothing to report.
Publication History
- Issue published online: 29 JUL 2009
- Article first published online: 9 JUL 2009
- Manuscript Accepted: 24 MAR 2009
- Manuscript Received: 21 NOV 2008
Funded by
- National Institutes of Health/National Institute on Drug Abuse. Grant Number: DA016175-01A1
- VA Pittsburgh Healthcare System
- VA Information Resource center
- National Patient Care Database
- Decisions Support System database
- Pharmacy Benefits Management database
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , Cost-effectiveness and Population Outcomes of General Population Screening for Hepatitis C, Clinical Infectious Diseases, 2012, 54, 9, 1259
- 2, , , , A Comparison of Treatment Eligibility for Hepatitis C Virus in HCV-Monoinfected Versus HCV/HIV-Coinfected Persons in Electronically Retrieved Cohort of HCV-Infected Veterans, AIDS Research and Human Retroviruses, 2011, 27, 9, 973
- 3, , , , , , A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C, Clinical Gastroenterology and Hepatology, 2011, 9, 6, 509
- 4, , Boceprevir and Telaprevir in the Management of Hepatitis C Virus-Infected Patients, Clinical Infectious Diseases, 2011, 54, 1, 96
- 5, , , , , , , , , Cancer preventive effect of pegylated interferon α-2b plus ribavirin in a real-life clinical setting in Japan: PERFECT interim analysis, Hepatology Research, 2011, 41, 10Direct Link:
- 6, , , , Economic Burden Associated With Patients Diagnosed With Hepatitis C, Clinical Therapeutics, 2011, 33, 9, 1268
- 7, , , , , The incidence, predictors and management of anaemia and its association with virological response in HCV / HIV coinfected persons treated with long-term pegylated interferon alfa 2a and ribavirin, Alimentary Pharmacology & Therapeutics, 2011, 33, 11Direct Link:
- 8, , Early Interferon-Based Treatment After Detection of Persistent Hepatitis C Virus Infection: A Critical Decision, Journal of Interferon & Cytokine Research, 2010, 30, 11, 817
- 9, , Hepatitis C and metabolic syndrome, Expert Review of Endocrinology & Metabolism, 2010, 5, 2, 209
- 10, , , , , , Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: Systematic review of randomized trials, Hepatology, 2010, 51, 4Direct Link:
- 11, , Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response, Current Hepatitis Reports, 2010, 9, 3, 147
- 12, , , , Quantum-dots-based detection of hepatitis C virus (HCV) NS3 using RNA aptamer on chip, Journal of Chemical Technology and Biotechnology, 2010, 85, 8Direct Link:
- 13, , , Utilization and Antiviral Therapy in Patients with Chronic Hepatitis C: Analysis of Ambulatory Care Visits in the US, Digestive Diseases and Sciences, 2010, 55, 6, 1744